Hematologia
Leczenie małopłytkowości
Effect of avatrombopag in the management of severe and refractory chemotherapy-induced thrombocytopenia (CIT) in patients with solid tumors. (opens new window)
Źródło: Platelets. 2022 3;33(7):1024-1030.
Indeks: PubMed 35040375
DOI: 10.1080/09537104.2022.2026910
https://pubmed.ncbi.nlm.nih.gov/35040375/ (opens new window)
Long-term follow-up for up to 5 years on the risk of leukaemic progression in thrombocytopenic patients with lower-risk myelodysplastic syndromes treated with romiplostim or placebo in a randomised double-blind trial. (opens new window)
Źródło: Lancet Haematol 2018;5(3):e117-e126.
Indeks: PubMed 29396092
DOI: 10.1016/S2352-3026(18)30016-4
https://www.ncbi.nlm.nih.gov/pubmed/29396092 (opens new window)